Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | CA 125 | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Buprenorphine Implant for Treatment of Opioid Dependence | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Bronchial Thermoplasty | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Breast Ductal Lavage for Detection of Breast Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Bone Turnover Markers for the Diagnosis and Management of Osteoporosis and Diseases Associated With High Bone Turnover | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Bone Mineral Density Studies | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Bioimpedance Devices for Detection and Management of Lymphedema | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Baroreflex Stimulation Devices | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Balloon Spacers for Treatment of Irreparable Rotator Cuffs of the Shoulder | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Axillary Reverse Mapping for Prevention of Breast Cancer-Related Lymphedema | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Autonomic Nervous System Testing Using Portable Automated Devices | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Automated Point of Care Nerve Conduction Tests | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Autologous Serum Eye Drops | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Autografts and Allografts in the Treatment of Focal Articular Cartilage Lesions | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Auditory Brainstem Implant | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Aqueous Shunts and Stents for Glaucoma | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Amniotic Membrane and Amniotic Fluid | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Ambulatory Blood Pressure Monitoring | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Ambulance: Ground Transport | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Allergy Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Adrenal-to-Brain Transplantation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Adjunctive Techniques for Screening, Surveillance, and Risk Classification of Barrett Esophagus and Esophageal Dysplasia | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Acute Hepatitis Panel | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Actigraphy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Absorbable Nasal Implant for Treatment of Nasal Valve Collapse | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Joint Replacement, Shoulder, Effective 11/1/2026 | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Intracoronary Drug Delivery Balloon Procedures Effective 9-1-26 | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Facet Arthroplasty, Effective 10/1/2026 | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Cosmetic Services Procedures Effective 1-1-2024 | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Rhode Island | Closure Devices for Patent Foramen Ovale and Atrial Septal Defects | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | ATTR Neuropathy and Cardiomyopathy | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | THROMBOPOIETIN RECEPTOR AGONISTS | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | HARLIKU | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | MASH/NASH Treatment | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | Rhapsido | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | Egrifta WR | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | Brinsupri | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | VANRAFIA | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | ZELSUVMI | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | VYKAT XR | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | ZEVASKYN | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | KEBILIDI | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | JOURNAX | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | CRENESSITY | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | AMTAGVI | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | TRYNGOLZA | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | OptimizeRx (excluding Armor Health prefixes YXN and YDB) | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | YORVIPATH | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | ZURZUVAE QUANTITY LIMIT | New policy |
| Aug 2, 2026 | Blue Cross and Blue Shield of Nebraska | NIEMAN-PICK DISEASE TREATMENT | New policy |